Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553019 · ClinicalTrials.gov registry record · Phase 2
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01553019: Completed Phase 2 study, sponsored by University of Florida.
NCT01553019 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01553019, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what effects, good and/or bad, proton radiation combined with chemotherapy has on resected pancreatic cancer.
Primary Outcome
Assessment of acute/late severe (defined as grade 3-5) radiation toxicity at the completion of therapy. Acute toxicity will be defined to be toxicity occurring within 90 days from the start of radiation treatment, and late toxicity will be defined as toxicity occurring more than 90 days from the start of radiation treatment.
Interventions
- DRUG Gemcitabine
- RADIATION Proton radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-10 |
| Est. Completion | 2017-08-31 |
| Phase | Phase 2 |
What the finished NCT01553019 record still lists
NCT01553019 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Gemcitabine is the first listed.
NCT01553019 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01553019 about?
NCT01553019 is a clinical study titled "Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer". The purpose of this study is to find out what effects, good and/or bad, proton radiation combined with chemotherapy has on resected pancreatic cancer.
What is the current status of trial NCT01553019?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2011-10. Estimated completion is 2017-08-31.
What interventions are being tested in trial NCT01553019?
The interventions under investigation include: Gemcitabine (DRUG), Proton radiation (RADIATION).
Who is sponsoring clinical trial NCT01553019?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01553019's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia